Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Chronic Lymphocytic Leukemia (CLL)”

2,169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,169 results

Not applicableNot Yet RecruitingNCT05371392
What this trial is testing

Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Sohag University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872
What this trial is testing

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 547
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Early research (Phase 1)Looking for participantsNCT06547528
What this trial is testing

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Who this might be right for
Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ono Pharmaceutical Co., Ltd. 108
Not applicableUnknownNCT03971565
What this trial is testing

Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Assistance Publique Hopitaux De Marseille 47
Testing effectiveness (Phase 2)Study completedNCT01532700
What this trial is testing

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT01373229
What this trial is testing

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
David Rizzieri, MD 21
Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT02533401
What this trial is testing

Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 34
Testing effectiveness (Phase 2)Looking for participantsNCT05147467
What this trial is testing

Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc. 75
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)WithdrawnNCT00845104
What this trial is testing

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Early research (Phase 1)UnknownNCT06209671
What this trial is testing

INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-cell
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT02968563
What this trial is testing

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 35
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01868893
What this trial is testing

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 20
Not applicableStudy completedNCT03582098
What this trial is testing

Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland

Who this might be right for
Chronic Lymphocytic Leukaemia
Gilead Sciences 112
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Not applicableStudy completedNCT02434484
What this trial is testing

Symbenda Post-Marketing Surveillance (PMS)

Who this might be right for
Lymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma
Eisai Korea Inc. 84
Not applicableNot Yet RecruitingNCT06364033
What this trial is testing

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL-like MBL+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 312
Load More Results